Yahoo Finance

Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
Medscape

Can Kids Be Given Injectable Dexamethasone Orally?

Adjunct Assistant Professor, Department of Psychiatry, Division of Child and Adolescent Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada A ...
Seeking Alpha

Protara Therapeutics Announces Alignment with FDA on Registrational Path Forward for IV Choline Chloride in Patients Dependent on Parenteral Nutrition

IV Choline Chloride has the potential to become the first FDA-approved IV formulation of choline for the 40,000 PN patients in the U.S. Approximately 80% of PN patients are choline deficient, which ...
Medscape

FDA Approves Teduglutide to Treat Short Bowel Syndrome

The US Food and Drug Administration (FDA) today approved teduglutide (Gattex, NPS Pharmaceuticals) to treat the estimated 10,000 to 15,000 American adults with short bowel syndrome (SBS). Teduglutide, ...
Business Wire

MEA Parenteral Nutrition Market Analysis By Type of Nutrition, Dosage Form, By Region, And Segment Forecasts, 2014 - 2025 - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MEA Parenteral Nutrition Market Analysis By Type of Nutrition (Carbohydrates, Parenteral Lipid Emulsions, Single Dose ...